Clinically significant mechanisms of bacterial resistance to aminoglycoside antibiotics involve the inactivation of these compounds by phosphotransferases, nucleotidyltransferases, and acetyltransferases (6, 7) . The production of these enzymes is generally plasmid mediated (8) . Accurate monitoring of the prevalence, genetic basis, and mechanism of resistance is required for the efficient control of aminoglycoside-resistant pathogens (1) . Such surveillance is actively carried out in human medicine (12) . However, the various mechanisms of bacterial resistance are less well documented in animal medicine. The first instance of plasmid-mediated coresistance to gentamicin and apramycin in bovine Escherichia coli strains, detected in France in 1984 (3, 5) , is due to the synthesis of type IV 3-N-acetyltransferase. We present here a study of E. coli strains from bovine samples that were resistant to gentamicin but not to apramycin due to a second mechanism of enzyme-mediated resistance.
From September 1985 to May 1986, all E. coli strains resistant to high levels of gentamicin (MIC, .128 ,ug/ml) and susceptible to apramycin (MIC, <16 p.g/ml) were collected by different district laboratories (16) . Only 13 such strains were isolated during this period in samples from 13 independent feedlots located in four noncontiguous districts. Four strains from the same district in central France were isolated from four herds situated within a 10-km radius of the same veterinary practice. All of the strains were isolated from fecal samples in cases of diarrhea or from different organs in cases of septicemia.
The antibiotic resistance of the gentamicin-resistant isolates was determined by disk diffusion on Mueller-Hinton agar (Diagnostics Pasteur). The MICs of gentamicin, kanamycin, and trimethoprim were determined by using the same medium. API-System galleries were used to identify and biotype the strains.
Conjugation was carried out overnight in brain heart infusion broth (Difco Laboratories) at 37°C with E. coli K-12 BM21 (prototroph, gyrA) or BM14 (pro met azi) as recipient (20) . The concentrations used for selection were as follows:
gentamicin, 8 ,ug/ml; nalidixic acid, 40 jig/ml; and sodium azide, 500 ,ug/ml. When possible, transconjugants resistant to gentamicin were tested in pairs for plasmid stability in the same host (2). * Corresponding author.
Plasmid DNA was prepared (19) and agarose gel electrophoresis was performed as described previously (15) . Plasmids RP4, pIP112 (10) , and those in strain V517 (13) were used as molecular size standards. The restriction endonucleases BamHI and Hindlll (Boehringer Mannheim Biochemicals) were used according to the recommendations of the manufacturer. Restriction endonuclease digestion of DNA was carried out after a rapid procedure for plasmid isolation (19) . Bacterial extracts were prepared, and the aminoglycoside-modifying enzymes were assayed by the phosphocellulose paper binding technique (9) . Chemicals were obtained as previously indicated (5).
The 13 E. coli strains were resistant to high levels of gentamicin (MIC, .128 ,ug/ml) but susceptible to apramycin.
This finding is in contrast to the first resistance phenotype described in France (4, 5), which was due to the production of the aminoglycoside 3-N-acetyltransferase type IV; this enzyme confers resistance to both gentamicin and apramycin (3). The 13 strains were resistant to ampicillin (MIC, >8 ,ug/ml), kanamycin (MIC, >1,024 ,ug/ml), tetracycline (MIC, >16 ,ug/ml), and sulfonamides (MIC, >350 ,ug/ml), and some were also resistant to trimethoprim (MIC, >1,024 j±g/ml), nalidixic acid (MIC, >64 ,ug/ml), and chloramphenicol (MIC, >32 ,uglml) (Table 1) . Only the four strains from central France belonged to the same biotype.
Analysis of crude bacterial lysates by agarose gel electrophoresis revealed the presence of one to six plasmids in the field strains. Every strain harbored one to three plasmids larger than 55 kilobases (kb) (Fig. 1) . Gentamicin-resistant transconjugants were obtained from all of the strains ( Table  1) ; 10 of these which had acquired a single plasmid were retained for further studies. The four strains from central France, which belonged to the same biotype, apparently harbored the same two plasmids (Fig. 1) We compared by agarose gel electrophoresis following digestion by two restriction endonucleases the six 110-kb plasmids and the four 80-to 130-kb plasmids. Plasmids from strains BN1232, BN1233, BN1287, and BN1290 yielded 12 BamHI (Fig. 2 ) and six HindIlI (data not shown) fragments with indistinguishable sizes. A comparison by agarose gel electrophoresis following digestion with BamHI of a representative of these four plasmids, pIP1832 from strain BN1232, with the six remaining plasmids resulted in six different restriction patterns (Fig. 3) . Some of the fragments were common to plasmids from strains BN477 and BN1076. A similar result was observed after digestion with EcoRI (data not shown).
Plasmids from strains BN1232, BN1233, BN1287, and BN1290 were tested for stable coexistence with plasmids from strains BN477 and BN1076. These plasmids could stably coexist in the same host after approximately 30 to 50 bacterial generations.
Gentamicin-resistant transconjugants from strains BN1232, BN1432, BN477, BN1076, BN1493, BN1494, and BN1387 contained aminoglycoside acetyltransferase activity. The substrate profile of the enzyme from strain BN477 is shown in Fig. 4 . The substrate profiles of the enzymes from the other strains were similar. Based on these substrate profiles, the enzyme is a type II aminoglycoside 3-N-acetyltransferase (6, 18) . This enzyme, which was first detected in hospital strains in France (11, 21) , is responsible for one of BN151 (N), and BM21(pIP112) (0). the most common phenotypes of resistance to gentamicin in Europe (14) . Production of this enzyme by animal isolates was apparently confined to a few strains in limited areas in France.
A single E. coli strain has apparently spread in four independent but close farms in central France. (Fig.  3) .
Plasmids from strains BN477 and BN1076 conferred resistance phenotypes which differed only with regard to ampicillin. Their BamHI-generated restriction patterns were distinct although related (Fig. 3 
